,headline,final_score,datetime
16,Kenvue's IPO Extravaganza: A Historic $41 Billion Spinoff from Johnson & Johnson,90,2023-05-04 09:24:50
35,Interesting JNJ Put And Call Options For June 23rd,60,2023-05-04 02:58:00
44,Johnson and Johnson IPO Today ��� Consumer Healthcare Unit Starts Trading at $22,86,2023-05-03 23:43:00
45,Johnson & Johnson`s (NYSE:JNJ) Arm Is Ready to Go Public,90,2023-05-03 23:27:00
46,Johnson & Johnson`s (NYSE:JNJ) Arm Ready to Go Public,90,2023-05-03 23:26:00
50,Johnson & Johnson stock outperforms market despite losses on the day,90,2023-05-03 20:34:00
58,Johnson & Johnson and Kenvue Announce Pricing of Upsized Kenvue Inc. Initial Public Offering,90,2023-05-03 16:22:00
60,Johnson & Johnson consumer arm valued at $41bn in biggest US IPO since 2021,90,2023-05-03 14:57:15
68,"With 71% institutional ownership, Johnson & Johnson (NYSE:JNJ) is a favorite amongst the big guns",90,2023-05-03 07:00:19
71,How Long Could It Take for Johnson & Johnson's Dividend Yield to Get to 5%?,90,2023-05-03 06:09:00
75,Johnson & Johnson Increases Dividend: What Shareholders Need To Know,90,2023-05-03 03:56:00
81,Johnson & Johnson`s Kenvue IPO to command valuation of more than $40 billion in biggest public debut since 2021,90,2023-05-02 23:39:00
84,"Johnson & Johnson`s Kenvue to price at $22 per share, Bloomberg says",90,2023-05-02 20:58:00
85,Johnson & Johnson stock underperforms Wednesday when compared to competitors,90,2023-05-02 20:34:00
87,Johnson & Johnson Ignites CAR-T Ambitions With Licensing Pact With Cellular Biomedicine,90,2023-05-02 11:14:29
92,Video: Dow Analyst Moves: JNJ,60,2023-05-02 04:37:00
93,Better Growth Stock: Johnson & Johnson vs. Intuitive Surgical,90,2023-05-02 04:20:00
94,See How Johnson & Johnson Ranks Among Analysts` Top Dow 30 Picks,90,2023-05-02 04:11:00
96,Johnson & Johnson projects earnings impact from CAR-T deal,90,2023-05-02 00:49:00
98,"Johnson & Johnson stock rises Tuesday, outperforms market",90,2023-05-01 20:34:00
102,Johnson & Johnson stock underperforms Monday when compared to competitors,90,2023-05-01 09:33:00
107,Johnson & Johnson Holding Value In Wake Of Lawsuits,90,2023-05-01 04:59:55
108,Johnson & Johnson reports 73% complete remission for bladder cancer therapy,90,2023-05-01 04:20:00
112,Johnson & Johnson reports first results from TAR-200 study,90,2023-04-30 19:51:00
121,A Johnson & Johnson (NYSE:JNJ) insider lowered their holding by 10% earlier this year,90,2023-04-29 05:00:19
127,"Johnson & Johnson stock rises Friday, still underperforms market",90,2023-04-28 09:33:00
130,Here's Why Johnson & Johnson (JNJ) is a Strong Value Stock,90,2023-04-28 06:40:01
133,Is It Too Late to Buy Johnson & Johnson's Stock?,90,2023-04-28 05:30:00
137,"Johnson & Johnson`s Kenvue targeted by talcum powder cancer claims, FT reports",90,2023-04-27 23:20:00
143,Dividend Champions vs Aristocrats: 12 Under-the-Radar Stocks to Consider,61,2023-04-27 10:14:11
150,The Shake-Up at NBCUniversal and Johnson & Johnson's Spinoff Plans,90,2023-04-27 07:43:29
154,See Which Of The Latest 13F Filers Holds Johnson & Johnson,90,2023-04-27 05:49:00
156,June 9th Options Now Available For Johnson & Johnson (JNJ),90,2023-04-27 02:55:00
165,JNJ's consumer unit targeted by talcum powder cancer claims - FT,60,2023-04-26 21:12:49
167,"Eli Lilly Earnings Are Soon. All Eyes Are on Its Diabetes Drug, Mounjaro.",61,2023-04-26 09:30:00
174,Johnson & Johnson: Reliable Dividend Of 2.9% With Steady Growth,90,2023-04-26 01:00:00
178,Johnson & Johnson to Participate in the Bernstein 39th Annual Strategic Decisions Conference,90,2023-04-25 13:30:00
180,Johnson & Johnson stock outperforms market on strong trading day,90,2023-04-25 09:33:00
183,"Final Trades: UnitedHealth, Johnson & Johnson & more",90,2023-04-25 06:42:38
190,Johnson & Johnson management to meet virtually with Oppenheimer,90,2023-04-24 20:55:00
198,Johnson & Johnson Announces Launch of Kenvue Inc. IPO Roadshow,90,2023-04-24 13:27:00
199,Investors Discuss News From Bank of America and Johnson & Johnson,90,2023-04-24 13:13:55
200,Johnson & Johnson spinoff Kenvue receives IPO value of $40 billion,90,2023-04-24 12:55:08
203,Johnson & Johnson prices consumer spinoff Kenvue at $20-$23 a share in IPO,90,2023-04-24 10:02:43
204,Johnson & Johnson aims to raise $3 billion in Kenvue IPO,90,2023-04-24 10:02:00
206,Johnson & Johnson to price shares of consumer spinoff Kenvue at $20 to $23 in IPO,90,2023-04-24 09:41:56
208,Johnson & Johnson stock outperforms competitors on strong trading day,90,2023-04-24 09:33:00
209,"Johnson & Johnson Unleashes Kenvue: Tylenol to Neutrogena, $40B Revenue Unit Spinoff Preps for IPO Blitz",90,2023-04-24 07:19:52
211,Are Investors Undervaluing Johnson & Johnson (NYSE:JNJ) By 25%?,90,2023-04-24 06:00:42
212,Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It,90,2023-04-24 06:00:01
